Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
Clinical trial NCT00270452 · COMPLETED
Trial details
- NCT number
- NCT00270452
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-22
- Primary completion
- 2007-10-26
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.